Literature DB >> 19056107

High-grade transitional cell carcinoma and melanosis of urinary bladder: case report and review of the literature.

Sharon L Sanborn1, Gregory MacLennan, Matthew M Cooney, Ming Zhou, Lee E Ponsky.   

Abstract

Melanosis of the urinary bladder is a rare entity. It is generally regarded as a benign condition, but it is sometimes associated with primary malignant melanoma of the urinary bladder. It has never been reported to be connected with transitional cell carcinoma. We present a case of a woman with melanosis of the bladder who a year later developed high grade transitional cell bladder carcinoma.

Entities:  

Mesh:

Year:  2008        PMID: 19056107     DOI: 10.1016/j.urology.2008.05.039

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Unusual case of simple urinary bladder melanosis with complete resolution.

Authors:  Zaid Mera; Sheena Patel; Omar Qassid; Roland England
Journal:  BMJ Case Rep       Date:  2018-04-25

Review 2.  Urinary tract transitional cell carcinoma and melanosis of the bladder: a case report and review of the literature.

Authors:  J A Harikrishnan; S Chilka; S Jain
Journal:  Ann R Coll Surg Engl       Date:  2012-05       Impact factor: 1.891

3.  Melanosis of the Bladder: Possible Pathogenetic Mechanisms.

Authors:  Justin E Dupey; Sarah J Wood; Richard Y Ball
Journal:  Case Rep Urol       Date:  2022-06-16

4.  Metastasis of Malignant Melanoma to Urinary Bladder: A Case Report and Review of the Literature.

Authors:  Rashna Meunier; Gyan Pareek; Ali Amin
Journal:  Case Rep Pathol       Date:  2015-05-28

5.  Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?

Authors:  Ulla Sammer; Matthias Walter; Stephanie C Knüpfer; Ulrich Mehnert; Beata Bode-Lesniewska; Thomas M Kessler
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

6.  Intravesical ichthyosis: a rare case report.

Authors:  T Hermans; R Grosse Siemer; F C von Rundstedt
Journal:  BMC Urol       Date:  2021-12-17       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.